3-112929282-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_138806.4(CD200R1):c.428G>A(p.Arg143His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000083 in 1,614,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_138806.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD200R1 | NM_138806.4 | c.428G>A | p.Arg143His | missense_variant | 4/8 | ENST00000308611.8 | NP_620161.1 | |
CD200R1 | NM_170780.3 | c.359G>A | p.Arg120His | missense_variant | 3/7 | NP_740750.1 | ||
CD200R1 | NM_138939.3 | c.428G>A | p.Arg143His | missense_variant | 4/4 | NP_620385.1 | ||
CD200R1 | NM_138940.3 | c.359G>A | p.Arg120His | missense_variant | 3/3 | NP_620386.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD200R1 | ENST00000308611.8 | c.428G>A | p.Arg143His | missense_variant | 4/8 | 1 | NM_138806.4 | ENSP00000311035.3 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251418Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135878
GnomAD4 exome AF: 0.0000794 AC: 116AN: 1461858Hom.: 0 Cov.: 78 AF XY: 0.0000770 AC XY: 56AN XY: 727228
GnomAD4 genome AF: 0.000118 AC: 18AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74436
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at